Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tamura

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Neuro-Oncology|April 1, 2024
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of <sup>11</sup>C-methionine in IDH-mutant astrocytomaToshihiro Yamamura, Kaoru Tamura, Daisuke Kobayashi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's diseaseMitsunori Watanabe, Yu Nakamura, Yasumasa Yoshiyama, et al.
World Neurosurgery|August 23, 2019
A Questionnaire to Assess the Challenges Faced by Women Who Quit Working as Full-Time NeurosurgeonsTaketoshi Maehara, Kazuko Kamiya, Takamitsu Fujimaki, et al.
Neuro-Oncology|November 19, 2022
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticityJamie A Dean, Shyam K Tanguturi, Daniel Cagney, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
Scientific Reports|September 21, 2023
Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumorsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology|October 26, 2021
12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumorsKaishi Satomi, Hirokazu Takami, Shintaro Fukushima, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Journal of Neuro-Oncology|May 22, 2015
Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumorsHirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, et al.
Acta Neuropathologica|January 7, 2017
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphomaTaishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|April 1, 2024
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of <sup>11</sup>C-methionine in IDH-mutant astrocytomaToshihiro Yamamura, Kaoru Tamura, Daisuke Kobayashi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 14, 2019
Analyses of natural courses of Japanese patients with Alzheimer's disease using placebo data from placebo-controlled, randomized clinical trials: Japanese Study on the Estimation of Clinical course of Alzheimer's diseaseMitsunori Watanabe, Yu Nakamura, Yasumasa Yoshiyama, et al.
World Neurosurgery|August 23, 2019
A Questionnaire to Assess the Challenges Faced by Women Who Quit Working as Full-Time NeurosurgeonsTaketoshi Maehara, Kazuko Kamiya, Takamitsu Fujimaki, et al.
Neuro-Oncology|November 19, 2022
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticityJamie A Dean, Shyam K Tanguturi, Daniel Cagney, et al.
Acta Neuropathologica|June 20, 2021
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaKenji Fujimoto, Hideyuki Arita, Kaishi Satomi, et al.
Scientific Reports|September 21, 2023
Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumorsHirokazu Takami, Kaishi Satomi, Kohei Fukuoka, et al.
Neuro-Oncology|October 26, 2021
12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumorsKaishi Satomi, Hirokazu Takami, Shintaro Fukushima, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Journal of Neuro-Oncology|May 22, 2015
Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumorsHirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, et al.
Acta Neuropathologica|January 7, 2017
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphomaTaishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, et al.
Pageof 6